Loading insider details...
Beta
Latest Form 4 (Jun 3, 2026): Grant/Award of 29,005 CVRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 3, 2026 | CVRx, Inc. (CVRX) | Grant/Award | 29,005 | n/a |
| Feb 27, 2026 | Axogen, Inc. (AXGN) | Grant/Award | 98,000 | n/a |
| Dec 12, 2025 | Axogen, Inc. (AXGN) | Sale | 25,000 | $750.0K |
| Dec 10, 2025 | Axogen, Inc. (AXGN) | Sale | 61,463 | $1.92M |
| Dec 5, 2025 | Axogen, Inc. (AXGN) | Grant/Award | 150,000 | n/a |
| Mar 26, 2025 | Axogen, Inc. (AXGN) | Grant/Award | 176,300 | n/a |
| Aug 9, 2024 | Axogen, Inc. (AXGN) | Grant/Award | 450,000 | n/a |
| Mar 3, 2023 | ABBOTT LABORATORIES (ABT) | Tax Withholding | 4,942 | $493.1K |
| Feb 22, 2023 | ABBOTT LABORATORIES (ABT) | Grant/Award | 9,504 | n/a |
| Mar 10, 2022 | ABBOTT LABORATORIES (ABT) | Sale | 4,000 | $468.0K |